WealthCollab’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17K Sell
481
-63
-12% -$1.95K 0.01% 413
2025
Q4
$15.2K Hold
544
0.01% 459
2025
Q3
$16.3K Hold
544
0.01% 404
2025
Q2
$15.6K Sell
544
-60
-10% -$1.79K 0.01% 385
2025
Q1
$19.9K Hold
604
0.01% 318
2024
Q4
$17.4K Hold
604
0.01% 341
2024
Q3
$16.9K Hold
604
0.01% 354
2024
Q2
$14.6K Buy
604
+198
+49% +$4.86K 0.01% 358
2024
Q1
$11K Hold
406
0.01% 416
2023
Q4
$11.3K Buy
+406
New +$10.5K 0.01% 382

Other funds holding ALKS

WealthCollab's ALKS Position: Q1 2026 in Review

WealthCollab reduced its Alkermes (ALKS) stake by 12% in Q1 2026, selling an estimated $1.95K and leaving 481 shares worth $17K. The position accounts for 0.01% of the portfolio, ranked #413.

WealthCollab first reported a position in ALKS in Q4 2023 and has held it in 10 quarters since. The position peaked at $19.9K in Q1 2025. 388 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • WealthCollab held 481 shares of Alkermes worth $17K as of Q1 2026.
  • WealthCollab sold 63 Alkermes shares in Q1 2026, an estimated $1.95K.
  • Alkermes made up 0.01% of WealthCollab's portfolio in Q1 2026, its #413 holding.
  • WealthCollab first reported a position in Alkermes in Q4 2023 and has held it in 10 quarters since.
  • WealthCollab's Alkermes position peaked at $19.9K in Q1 2025.
  • 388 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.